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ABSTRACT 
All protein-encoding genes in eukaryotes are transcribed into messenger RNA (mRNA) by RNA 
Polymerase II (RNAP II), whose activity therefore needs to be tightly controlled. An important 
and only partially understood level of regulation is the multiple phosphorylations of RNAP II 
large subunit C-terminal domain (CTD). Sequential phosphorylations regulate transcription 
initiation and elongation, and recruit factors involved in co-transcriptional processing of mRNA. 
Based largely on studies in yeast models and in vitro, the kinase activity responsible for the 
phosphorylation of the serine-5 (Ser5) residues of RNAP II CTD has been attributed to the 
Mat1/Cdk7/CycH trimer as part of Transcription Factor IIH. However, due to the lack of good 
mammalian genetic models, the roles of both RNAP II Ser5 phosphorylation as well as TFIIH 
kinase in transcription have provided ambiguous results and the in vivo kinase of Ser5 has 
remained elusive. 
 
The primary objective of this study was to elucidate the role of mammalian TFIIH, and 
specifically the Mat1 subunit in CTD phosphorylation and general RNAP II-mediated 
transcription. The approach utilized the Cre-LoxP system to conditionally delete murine Mat1 in 
cardiomyocytes and hepatocytes in vivo and and in cell culture models. The results identify the 
TFIIH kinase as the major mammalian Ser5 kinase and demonstrate its requirement for general 
transcription, noted by the use of nascent mRNA labeling. Also a role for Mat1 in regulating 
general mRNA turnover was identified, providing a possible rationale for earlier negative 
findings. 
 
A secondary objective was to identify potential gene- and tissue-specific roles of Mat1 and the 
TFIIH kinase through the use of tissue-specific Mat1 deletion. Mat1 was found to be required for 
the transcriptional function of PGC-1 in cardiomyocytes. Transriptional activation of lipogenic 
SREBP1 target genes following Mat1 deletion in hepatocytes revealed a repressive role for 
Mat1apparently mediated via co-repressor DMAP1 and the DNA methyltransferase Dnmt1. 
Finally, Mat1 and Cdk7 were also identified as a negative regulators of adipocyte differentiation 
through the inhibitory phosphorylation of Peroxisome proliferator-activated receptor (PPAR) γ. 
Together, these results demonstrate gene- and tissue-specific roles for the Mat1 subunit of TFIIH 
and open up new therapeutic possibilities in the treatment of diseases such as type II diabetes, 
hepatosteatosis and obesity. 
 
.  
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REVIEW OF THE LITERATURE  
 
I. RNA Polymerase II-mediated transcription 
 
The genetic blueprint for the building blocks of all living organisms on Earth is contained 
within their DNA. Transcription by RNA polymerase II (RNAP II) is the process of 
copying a defined sequence of DNA into a complementary messenger RNA (mRNA) 
sequence, which is then translated into proteins by ribosomes. In addition to RNAP II, 
eukaryotic cells contain two other polymerases: RNAP I which transcribes the majority 
of ribosomal RNA (rRNA) and RNAP III, which is responsible for producing transfer 
RNA (tRNA), 5S rRNA and other small RNAs. RNAP II-mediated transcription is 
divided into four stages: initiation, promoter escape, elongation and termination. 
Regulation of transcription by RNAP II is the key event in determining the fate of any 
given cell, and thus it is not surprising that this regulation is complex. Classically, 
regulation of transcription initiation is thought to occur via binding of specific 
transcription factors to promoters and enhancers of a given gene, which recruit the 
general transcription factors (GTFs) and the polymerase machinery to the scene. 
Following formation of this pre-initiation complex (PIC), RNAP II escapes the PIC and 
progresses into elongation to produce the nascent transcript. Once the polymerase 
encounters the termination signal at the end of the gene, it exits the DNA and is ready to 
begin a new transcription cycle.  
 
Recent genome-wide maps of RNAP II distribution in human and Drosophila have 
demonstrated that in addition to RNAP II recruitment to promoters, transcription is also 
often regulated at the stage of progression into elongation: many genes contain a 
promoter-proximal paused polymerase (Guenther et al., 2007).  These genes are often 
ones that require rapid activation in response to external stimuli (Muse et al., 2007) as 
well as genes involved in pattern formation during development (Wang et al., 2007; 
Zeitlinger et al., 2007). Hence the paused polymerase is thought to provide a swift means 
of temporal and special regulation for transcription. However, regardless of the status of 
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RNAP II, all nuclear protein-encoding genes in eukaryotes exist as chromatin and their 
mRNAs are mostly processed in the same way to produce mature transcripts. 
 
The chromatin template  
 
In eukaryotes, DNA is packaged into chromatin, the main constituents of which are 
nucleosomes: 147 base pairs of DNA wrapped around highly basic histone octamers 
(Figure 1). The histone octamers consist of two H2A-H2B dimers and an H3-H4 
tetramer. Between the core nucleosomes, the DNA is occupied by a linker histone, H1, 
which can additionally compact the chromatin. The chromatin structure and nucleosome 
positioning relate directly to transcription: tightly packed chromatin is often silent 
whereas highly transcribed regions and, in particular promoters, associate with lower 
nucleosome occupancy (Bernstein et al., 2004; Lee et al., 2004; Lee et al., 2007; Sekinger 
et al., 2005). In order for RNAP II to progress along the DNA, the tightly packed 
chromatin template must be altered; this involves partial disassembly of nucleosomes by 
chromatin remodellers such as Swi/SNF, FACT and Spt6 (Belotserkovskaya et al., 2003; 
Ivanovska et al., 2010 ; Takahata et al., 2009) as well as histone modifications. The major 
histone modifications are acetylation, methylation, phosphorylation and ubiquitination; 
the combination of these modifications is termed the ‘histone code’ (reviewed in 
Jenuwein and Allis, 2001). These modifications directly influence the physical structure 
of the chromatin to enable or alternatively block the passage of RNAP II and additionally 
recruit other co-regulatory proteins that control transcription progression. These 
modifications are discussed in more detail in ‘Chromatin modifications’.  
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Figure 1. The chromatin template and the core promoter. The genetic information of eukaryotes in 
chromosomes is packaged into chromatin, which consists of DNA and histone proteins. 147 bp of DNA 
wrapped around histone octamers forms the core component of chromatin: the nucleosome. Transcription 
of DNA into mRNA begins from the transcription start site (TSS), which is located in the core promoter 
region. The main constituents of the core promoter are the TFIIB recognition element (BRE), TATA box, 
Initiator element (Inr) and the downstream promoter element (DPE), which together dictate where RNA 
Polymerase II and the transcription machinery assemble. 
 
Although the structure of the entire chromatin template affects transcription and vice 
versa, it is specific sequences in the DNA that dictate where the PIC is assembled. The 
core promoter is the nucleotide sequence in DNA to which the transcription machinery 
binds in order to initiate transcription. Most promoters exist in nucleosome-free regions 
(NRFs), regardless of their status of transcriptional activity (Albert et al., 2007; Lee et al., 
2007; Mavrich et al., 2008; Shivaswamy et al., 2008). Two types of core promoters exist: 
focused and dispersed. The majority of vertebrate promoters are dispersed: they contain 
numerous transcription start sites (TSS) diffused along 100 bp (Carninci et al., 2005; 
Carninci et al., 2006). A typical focused core promoter is composed of several 
nucleotides and includes one TSS or a cluster of start sites. Focused promoters are often 
found on tissue-specific genes and typically contain the consensus sequence TATAA 
termed the TATA box located 28-34 bp upstream of the TSS, which recruits the TATA-
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binding protein (TBP) (Carninci et al., 2006). Dispersed promoters are common in 
ubiquitously expressed genes and typically have CpG islands, genomic stretches enriched 
with GC dinucleotides, which can be methylated to repress transcription (Carninci et al., 
2006). In addition to the TATA box, the paramount core promoter motifs are the TFIIB 
recognition element BRE, the initiator element (Inr), and the downstream promoter 
element, DPE (reviewed in Smale and Kadonaga, 2003) (Figure 1). All, some or none of 
these elements may be included in a particular core promoter. The Inr comprises the start 
site for transcription and is functionally similar to the TATA box in that they are the only 
known promoter elements that can alone recruit PIC (Smale and Baltimore, 1989). The 
DPE is typically found in TATA-less promoters and acts in conjunction with the Inr as a 
TFIID binding site (Zhou and Chiang, 2001). In classic PIC assembly, TFIID binds to 
these core elements either through TBP or TAFs (transcription associated factors), 
followed by sequential recruitment of the other GTFs: TFIIA, TFIIB, TFIIF, TFIIE and 
TFIIH (reviewed in Baumann et al., 2010). To initiate transcription, accessory factors 
such as the Mediator, chromatin modifiers, and co-activators are often required in the 
vicinity of the promoter (reviewed in Malik and Roeder, 2010). The basic structure of the 
core promoter and chromatin is depicted as a schematic in Figure 1. 
 
In addition to the promoter elements described above, core promoters may contain the 
more rare sequence motifs Downstream core element (DCE) (Lewis et al., 2000), X core 
promoter element 1 (XCPE1) (Tokusumi et al., 2007) and Motif ten element (MTE) (Lim 
et al., 2004). Although the role of core promoter elements in PIC assembly and TSS 
definition has been widely accepted, it should be noted that recent advances in 
nucleosome profiling have led to speculations that nucleosome positioning may 
determine the location of the TSS and dictate PIC assembly (reviewed in Jiang and Pugh, 
2009). 
 
Phosphorylation of the C-terminal domain of RNA PII 
 
Comprising at least 12 distinct subunits and with a molecular mass of over 500 kD, 
eukaryotic RNA polymerase II is the protagonist in transcription of mRNA. The C-
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terminal domain (CTD) of the largest subunit of RNAP II (Rpb1) holds a unique, highly 
conserved feature: a tandem repeat of the heptapeptide consensus sequence YSPTSPS. 
The repeat length varies: yeast has 26-27 repeats, C. elegans contains 34 repeats, 
Drosophila carries 43 repeats, and the human and mouse have 52 (reviewed in Egloff and 
Murphy, 2008). The CTD is essential for viability: deletion analyses and truncation 
mutants show that the minimal length of 11 repeats in yeast and 29 repeats in human cells 
is necessary for survival (Bartolomei et al., 1988; Nonet et al., 1987). The CTD 
heptapeptide repeat can be phosphorylated at the three serine residues of the consensus 
sequence, Ser2, Ser5 and Ser7 (Akhtar et al., 2009; Chapman et al., 2007; Glover-Cutter 
et al., 2009; Kim et al., 2009; Zhang and Corden, 1991), and to some extent, tyrosine and 
threonine residues (Baskaran et al., 1993; Zhang and Corden, 1991).  
 
The Ser5 phosphorylated form of RNAP II  is mainly localized to 5’-ends of genes where 
transcription initiation occurs, whereas RNAP II containing phosphorylations of the Ser2 
residue has been detected further in gene bodies and therefore associated with elongation 
(Figure 2) (Cheng and Sharp, 2003; Donner et al., 2010; Glover-Cutter et al., 2009; 
Morris et al., 2005). Ser7 has been demonstrated to be crucial for the transcription of 
snRNAs, but not for protein-encoding genes (Egloff et al., 2007). After RNAP II has 
finished transcribing, it is dephosphorylated by CTD phosphatases FCP1 (Lin et al., 
2002b) and SCP1 (Yeo et al., 2003), and the unphosphorylated polymerase can re-enter a 
PIC to initiate another cycle of transcription (Figure 2). As RNAP II progresses along the 
gene, the sequential phosphorylations of the CTD create a dynamic scaffold for 
chromatin modifiers and mRNA processing enzymes, temporally coordinating the length 
and maturity of the nascent transcript. This coupling has often been termed the ‘CTD 
code’ (reviewed in Egloff and Murphy, 2008), and its implications are discussed in detail 
in the secion entitled ‘mRNA processing’). 
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Figure 2. Schematic representation of the CTD phosporylation cycle. (1) General transcription factors 
(GTFs) and RNA Polymerase II (RNAPII) assemble at the promoter (here depicted by TATA) to form the 
pre-initiation complex (PIC). (2) TFIIE recruits TFIIH to the PIC, which co-incides with the 
phosphorylation of the C-terminal domain (CTD) of RNAPII on Serine 5 residues. This results in promoter 
escape, and the transcription of ∼30 nucleotides of mRNA. At this stage, RNAPII can either pause or 
proceed onto elongation. (3) At the elongation stage, P-TEFb is recruited to the transcription site and 
RNAPII CTD is further phosphorylated on Serine 2 residues. This results in progression of elongation and 
transcription of the rest of the gene. (4) After RNAPII has finished transcribing, the CTD is 
dephosphorylated by phosphatases, and it can be recycled to begin a new transcription cycle (5).  
 
Transcriptional cell-cycle dependent kinases (Cdks) are the major encoders responsible 
for molding the CTD. To date, the majority of in vitro and in vivo data indicate that the 
Ser2 residues are phosphorylated by Cdk9 as part of Positive transcription elongation 
factor b (P-TEFb) (reviewed in Peterlin and Price, 2006). Recently, Cdk7 has been 
identified as the kinase responsible for Ser7 phosphorylation (Akhtar et al., 2009; Glover-
Cutter et al., 2009; Kim et al., 2009). In vitro, Ser5 of RNAP II can be phosphorylated by 
Cdk7 but in addition, a number of other kinases, such as Cdk8, Cdk9, and MAPK 
(Gomes et al., 2006; Ramanathan et al., 2001; Rickert et al., 1999; Trigon et al., 1998; 
Zhou et al., 2000). Since Cdk7 as part of TFIIH is recruited to promoters upon 
transcription induction and coincides with Ser5 phosphorylation, Cdk7 has been one of 
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the best candidates for the in vivo kinase (Cheng and Sharp, 2003; Komarnitsky et al., 
2000; Schwartz et al., 2003; Spilianakis et al., 2003). Figure 2 illustrates the RNAP II 
CTD phosphorylation cycle during transcription  
 
TFIIH and Mat1 
 
The general transcription factor IIH (TFIIH) is a conserved protein complex required for 
RNAP II-mediated transcription and for nucleotide excision repair (Drapkin et al., 1994; 
Schaeffer et al., 1993; van Vuuren et al., 1994; Wang et al., 1994). TFIIH consists of ten 
subunits divided into a core (p5, p34, p44, p52, p66, XPB, XPD) (Giglia-Mari et al., 
2004) and a kinase (Mat1, Cdk7, Cyclin H) submodule apparently not required for DNA 
repair (Coin et al., 2008) (Figure 3). The helicase activity of the XPB core subunit is 
required for general transcription at the stage of transcription initiation to melt promoter 
DNA (reviewed in Saunders et al., 2006).  
 
In mammalian cells, the kinase submodule consists of the catalytic cyclin-dependent 
kinase Cdk7 (Roy et al., 1994), its cognate cyclin CycH (Serizawa et al., 1995; 
Shiekhattar et al., 1995), and a third subunit Mat1 (Adamczewski et al., 1996) required 
for stability of the complex in vitro (Devault et al., 1995; Tassan et al., 1995) and in vivo 
(Korsisaari et al., 2002; Rossi et al., 2001) (Figure 3). This submodule has been 
implicated in many functions not related to general transcription - and indeed partly 
independently of core TFIIH (Li et al., 2010): cell cycle regulation as the Cdk-activating 
kinase CAK (Larochelle et al., 2007; Li et al., 2010), differentiation (Patel and Simon, 
2010; Wang et al., 2006), and regulation of specific transcriptional activators (Compe et 
al., 2005; Keriel et al., 2002; Rochette-Egly et al., 1997).  
 
The Mat1 subunit is a 36-37 kD protein with a hydrophobic C-terminal domain, a central 
coiled-coil domain and an N-terminal RING-finger motif which contains a zinc-binding 
domain (Busso et al., 2000). The RING finger has the typical ββαβ topology of the 
RING family, but additionally, it accommodates a short α-helix and an extended basic 
surface, which may be required for the characteristic activities and regulation of Mat1 
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(Gervais et al., 2001). The RING-finger motif is associated with TFIIH-mediated 
transcriptional activation; its deletion inhibits basal transcription and phosphorylation of 
the CTD of RNAP II (Busso et al., 2000; Warren, 2002). Deletion mutant analysis shows 
that the hydrophobic and coiled-coil domains of Mat1 join the CAK complex to the N-
terminal region of XPD (Sandrock and Egly, 2001) and perhaps also to XPB (Busso et 
al., 2000), which links it to the core TFIIH through interactions with p44. The C-terminal 
hydrophobic domain interacts with the Cdk7-Cyclin H dimer; according to 
coimmunoprecipitation studies, Mat1 is able to bind to both subunits independently and 
that this domain appears to be sufficient for Cdk7 kinase activity (Busso et al., 2000).  
XPD
XPB
Mat1
cycH
p34
p52
p62
p44
Cdk7
core TFIIH
Kinase submodule
(CAK)
 
 
The Cdk7 submodule of TFIIH was first suggested to be involved in regulation of general 
transcription when it was found to phosphorylate the C-terminal domain (CTD) of 
mammalian RNAP II (Mäkelä et al., 1995; Serizawa et al., 1995; Shiekhattar et al., 
1995). The TFIIH kinase can phosphorylate Ser5 of the CTD (Gebara et al., 1997; Roy et 
al., 1994; Trigon et al., 1998), and on mammalian genes localization of Ser5 
phosphorylated RNAP II is consistent with promoter clearance (Cheng and Sharp, 2003; 
Donner et al., 2010; Gomes et al., 2006; Morris et al., 2005). However, genetic studies on 
the role of Cdk7 and the TFIIH kinase in Ser5 phosphorylation and general transcription 
do not provide a unified picture even in the most extensively studied budding yeast 
system, where temperature-sensitive alleles of the TFIIH kinase demonstrate dramatically 
Figure 3. Cartoon of TFIIH 
structure. TFIIH consists of 7 
subunits forming the core TFIIH 
(XPD, XPB, p62, p52, p44, p34, p5 
(not depicted here)) and three subunits 
which make up the kinase submodule 
(Mat1, Cdk7, Cyclin H), also termed 
the Cdk-activating kinase (CAK).  The 
cartoon is based on documented 
interactions between Mat1-XPD 
(Sandrock and Egly, 2001),  Mat1- 
Cdk7-CycH(Busso et al., 2000), p44-
XPB (Iyer et al., 1996), p52-XPB 
(Coin et al., 2007), p34-p44 (Fribourg 
et al., 2001) and p44-XPB  (Coin et 
al., 1999) as well as the molecular 
structure of TFIIH resolved by 
electron microscopy (Muse et al., 
2007; Schultz et al., 2000).  
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reduced mRNA levels (Faye et al., 1997; Holstege et al., 1998; Valay et al., 1995). In one 
study, RNAP II occupancy was dramatically decreased (Schroeder et al., 2000) whereas 
another reported only a modest decrease in RNAP II occupancy despite a general loss of 
Ser5 phosphorylation (Ser5-P) (Komarnitsky et al., 2000). Subsequent studies using 
analogue-sensitive KIN28 (Cdk7 homolog) alleles either show no significant global 
change in mRNA levels, or in occupancy, while Ser5 phosphorylation and capping are 
decreased (Kanin et al., 2007) or show a significant decrease in mRNA levels without 
major changes in occupancy or Ser5 phosphorylation (Hong et al., 2009).  
 
In fission yeast Mcs6 (Cdk7 homolog) ts mutants demonstrate a moderate decrease in 
total Ser5-P and a 35% reduction in median mRNA abundance (Lee et al., 2005) whereas 
,inhibition of an analog-sensitive Msc6 allele leads to decreased global Ser5-P but not a 
global deregulation of mRNAs (Viladevall et al., 2009). In C. elegans, partial loss of 
Cdk7 resulted in decreased global Ser5-P as well as defective transcription (Wallenfang 
and Seydoux, 2002). Cdk7 temperature-sensitive mutants in Drosophila in some studies 
do not display transcriptional defects (Larochelle et al., 1998), whereas in others defects 
have been noted in early zygotic transcription (Leclerc et al., 2000) or on the widely 
studied hsp70 locus (Schwartz et al., 2003). In the latter study, a decrease in Ser5-P was 
not associated with the transcriptional defects.  
 
In mammalian systems two genetic approaches have been used to investigate the role of 
the endogenous TFIIH kinase in Ser5 phosphorylation and general transcription. Despite 
decreased Ser5 and Ser2 phosphorylation, no defect was noted in murine Mat1-/- embryo 
outgrowths in their ability to express GFP from microinjected plasmids (Rossi et al., 
2001), and loss of Mat1 from Schwann cells did not lead to phenotypes consistent with 
general transcriptional defects (Korsisaari et al., 2002). In HCT116 human cancer cells 
with an integrated ATP-analogue sensitive Cdk7 allele, addition of the inhibitor (3-MB-
PP1) did not detectably block general transcription or result in Ser5-P changes at global 
levels or on the studied genes c-myc and gapdh (Glover-Cutter et al., 2009; Larochelle et 
al., 2007). Therefore, the evidence for TFIIH in Ser5 phosphorylation and general 
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transcription across species has been controversial and the mammalian in vivo Ser5 
kinase remained elusive. 
 
Co-transcriptional mRNA processing 
 
The transcription of a gene is not enough to produce a mature transcript that can be 
translated into protein: the nascent transcript must additionally be processed into 
messenger RNA (mRNA). This includes co-transcriptional capping of the protruding 
5’end of the nascent mRNA, splicing of introns and polyadenylation of the pre-mRNA. 
All these processes have been linked to phosphorylation of RNAP II CTD as described in 
detail below.  
 
Capping, the first step in mRNA maturation, is the process through which a guanine 
nucleotide at the 5’end of the pre-mRNA is methylated on the 7-position by cap 
methyltransferase (Figure 4). This 7-methylguanosine (m7G) cap is thought to provide 
stability to the newly transcribed mRNA by protecting it from 5-exonucleases. In vitro, 
phosphorylated RNAP II CTD stimulates capping enzyme activity (Ho and Shuman, 
1999). Furthermore, capping enzymes directly associate with Ser5-phosphorylated RNAP 
II CTD (Cho et al., 1997; McCracken et al., 1997a). Studies in both budding and fission 
yeast demonstrate that capping enzymes are recruited by Ser5 phosphorylated RNAP II 
and in turn, recruit Cdk9 to phosphorylate Ser2 (Guiguen et al., 2007; Pei et al., 2003; 
Qiu et al., 2009; Viladevall et al., 2009). Similarly, in Drosophila resumption of 
elongation of a paused RNAP II is correlated with Ser5 CTD phosphorylation (O'Brien et 
al., 1994) and capping (Rasmussen and Lis, 1993), whereas P-TEFb and Ser2 
phosphorylation are noted on genes after the pause site (Boehm et al., 2003). Therefore, 
current data shows that capping occurs simultaneously to RNAP II pausing 
approximately 30 bp downstream from the TSS and may therefore provide a potential 
checkpoint for progression into elongation. 
 
The majority of eukaryotic pre-mRNA is composed of non-coding sequences, introns, 
which must be spliced out to form the mature mRNA (Figure 4). Eukaryotic cells contain 
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two types of introns: the more common U2-type introns and the highly conserved, less 
common U12-type introns, which are present in a small subset of “information 
processing genes” (reviewed in Patel and Steitz, 2003).  This removal of introns is 
achieved by the spliceosome, which is made up of uridine-rich small nuclear RNAs (U 
snRNAs), working together with over 200 auxiliary proteins, often termed splicing 
factors (reviewed in Valadkhan and Jaladat, 2010). The spliceosomal snRNAs recognize 
the intron-exon boundaries through base-pairing to a consensus sequence and the intron is 
removed by two consecutive transesterification reactions. Phosphorylated CTD has been 
shown in vitro to stimulate splicing activity (Hirose et al., 1999; Millhouse and Manley, 
2005), and in vivo hypophosphorylated RNAP II co-localizes and associates with splicing 
factors (Mortillaro et al., 1996). In Xenopus oocytes, blocking CTD phosphorylation with 
kinase inhibitors dimishes transcription-coupled splicing (Bird et al., 2004). Spt6 mutants 
that are unable to bind Ser2 phosphorylated CTD display splicing defects, suggesting one 
possible mediator between splicing and CTD phosphorylation (Yoh et al., 2007).  
 
The final step in producing a mature mRNA is polyadenylation, where the 3’end of the 
transcript is first cleaved endonucleolytically after an AAUAAA sequence followed by 
the addition of a poly(A) tail consisting of multiple adenosine monophosphates (Figure 
4). This is catalyzed by the multisubunit enzyme complexes CstF and CPSF in mammals 
(Perez Canadillas and Varani, 2003). The poly(A) tail stabilizes the mRNA and targets it 
for translation and nuclear export. Budding yeast ctk1 (Ser2 kinase) mutant strains that 
lack Ser2 phosphorylation are unable to recruit polyadenylation factors (Ahn et al., 2004) 
and although both nonphosphorylated and phosphorylated RNAP II bind CstF and CPSF 
similarly in vitro, the phosphorylated form is more active in an endonuclease cleavage 
assay (Hirose and Manley, 1998). 
 
Interestingly, comparison of truncation mutants has revealed that different segments of 
the CTD independently stimulate either capping, splicing or 3’-end processing (Fong and 
Bentley, 2001). This suggests that specific CTD repeats may be differentially 
phosphorylated during the transcription cycle to recruit the necessary factors, providing 
yet higher specificity to the CTD code. 
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Figure 4. Transcription-coupled mRNA processing. (1) A 7-methylguanosine cap is added to the 
protruding nascent pre-mRNA by the capping machinery to protect it from nuclease activity. The capping 
machinery is recruited to the site of transcription by Ser5 phosphorylated RNAP II. (2) Capping enzymes 
recruit P-TEFb, which phosphorylates RNAP II CTD on Ser2. This provides a potential ‘checkpoint’ 
whether or not to proceed onto transcript elongation. (3) Non-coding introns are removed during 
transcription elongation by spliceosomes. (4) A poly-A tail is added to the pre-mRNA, the mRNA is 
cleaved and ready to be transported to the cytosol for translation into proteins by ribosomes. 
 
Regulation of mRNA stability and decay 
 
In addition to transcription rate, the abundance of mRNAs is also regulated by their 
stability and decay, which in turn can be reflected on the amount of protein produced 
from the transcript. Typically, mRNAs with short half-lives encode proteins that need to 
be produced quickly in response to external stimuli, whereas stable mRNAs with long 
half-lives represent constitutively and highly expressed genes such as house-keeping 
genes or maternal mRNAs (reviewed in Guhaniyogi and Brewer, 2001). 
 
Several different mRNA decay pathways exist in mammalian cells, and they may all 
work in concert or separately from one another. In the deadenylation pathway, the 
protective poly(A) tail is chewed off by at least one poly(A) ribonuclease (PARN) 
(Korner and Wahle, 1997; Korner et al., 1998). To hasten the process, the stabilizing 
5’cap is also removed, and the mRNA is bidirectionally degraded by exonucleases. The 
process of mRNA decay once again highlights the importance of proper mRNA 
processing to protect the nascent transcript. The complex responsible for mRNA 
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degradation has been termed the exosome and consists almost exclusively of 
exoribonucleic proteins. mRNAs can also be degraded by a deadenylation-independent 
pathway.  In this process, RNA endonucleases recognize specific sequences within the 
mRNA and begin to chew up the transcript from within (reviewed in Guhaniyogi and 
Brewer, 2001). In addition to normal mRNA turnover, the exosome functions as a quality 
controller of pre-mRNA: if any of the mRNA processing steps are faulty, the mRNA is 
degraded (reviewed in Raijmakers et al., 2004). Lastly, the nonsense-mediated decay 
pathway (NMD) targets aberrant transcripts formed during transcription, serving as an 
mRNA surveillance mechanism and preventing the formation of truncated proteins 
(reviewed in Chang et al., 2007). 
 
mRNA turnover can be regulated at individual transcript level by specific sequence 
elements, the best studied to date being the adenylate-uridylate rich elements (AREs) 
located in the 3’ untranslated region (3’UTR). These elements have been found in a 
number of proto-oncogenes, growth factors and cytokines (Bakheet et al., 2001). External 
cues signal ARE-binding proteins to localize to these elements, hence either stabilizing 
them or hastening their turnover by promoting decay. For example, mRNA levels of 
vascular endothelial growth factor (VEGF) rise in response to hypoxia due to binding of 
the HuR protein to AREs in VEGF 3’UTR, resulting in increased stability and longer 
half-life (Levy et al., 1998). In addition to AREs, other decay determinants that have been 
identified include iron-response element (IRE), C-rich element and JNK-response 
element (Guhaniyogi and Brewer, 2001).  
 
In addition to transcript-specific stabilization, widespread changes in mRNA turnover 
have been noted in budding yeast, where 36.2% of mRNAs show altered stability 
following oxidative stress (Molina-Navarro et al., 2008). In mammalian cells, studies 
comparing mRNA steady-state levels and nascent transcription following transcriptional 
inhibition have suggested general stabilization of mRNAs (Dolken et al., 2008; Friedel et 
al., 2009; Meininghaus et al., 2000), although this phenomenon has yet to be widely 
recognized. Nevertheless, recent advances in studying nascent transcription by labeling 
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newly transcribed mRNA have highlighted the importance of mRNA turnover in the 
regulation of transcript levels. 
 
Chromatin modifications 
 
To provide a yet higher level of regulation and specificity to gene expression, the 
chromatin template itself can be modified through enzymatic activities. This comprises 
DNA methylation and covalent post-translational modifications of histones: acetylation, 
methylation, phosphorylation, ADP-ribosylation, ubiquitination and biotinylation 
(reviewed in Vaquero et al., 2003). Histone tail modifications are typically dynamic and 
transient, whereas DNA methylation can be passed on through cell divisions and 
generations, and forms the core of epigenetic inheritance. 
 
Histones are modified on their N-terminal tails, and the various modifications change 
their affinity towards different proteins, determining for e.g. which transcription factors, 
chromatin modifiers, and enhancers are recruited to the DNA. Acetylation is the most 
extensively studied histone modification and is mostly associated with transcriptional 
activation (Bernstein et al., 2005; Pokholok et al., 2005; Schubeler et al., 2004). 
Therefore, it is not surprising that many transcriptional co-activators such as Gcn5 
(Imoberdorf et al., 2006), p300/CBP (Ogryzko et al., 1996) and TAF250 (Mizzen et al., 
1996) contain histone acetyltransferase (HAT) activity. HATs catalyze the transfer of an 
acetyl group from acetyl coenzyme A to lysine residues of H2B, H3 and H4 (reviewed in 
Vaquero et al., 2003) and it is hypothesized that this modification partially neutralizes the 
positively charged histones, hence loosening their grip on the DNA. The removal histone 
acetylations is catalyzed by histone deacetylases (HDACs), which are therefore involved 
in transcriptional repression (Hu et al., 2000). 
 
Methylation can take place on arginine and lysine residues of H3 and H4. The transfer of 
methyl groups from S-adenosyl-L-methionine (SAM) to these residues is catalyzed by 
histone methyltransferases (HMTs) and conversely removed by histone demethylases 
(HDMs) (reviewed in Zhang and Reinberg, 2001). Interestingly, HMTs Set1 and Set2, 
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which catalyze H3 lysine 4 (H3K4) methylation and H3 lysine 36 (H3K36) methylation 
respectively, interact with phosphorylated RNAP II CTD (Krogan et al., 2003; Li et al., 
2003; Xiao et al., 2003), providing a direct link between sequence-specific regulation and 
the general transcription machinery. In particular, H3K4 trimethylation appears to require 
Cdk7 kinase activity in yeast (Ng et al., 2003). Genome-wide studies have shown that 
H3K4 methylation is associated with active transcription and occurs in the vicinity of 
transcription start sites, whereas H3K36 methylation occurs in the bodies of actively 
transcribed genes (Bernstein et al., 2005; Guenther et al., 2007; Pokholok et al., 2005; 
Santos-Rosa et al., 2002). Methylated H3K9 on the other hand, has been shown to 
localize to sites of repressed chromatin (Ebert et al., 2006). 
 
Additionally, histones can undergo phosphorylation, ubiquitination and ADP-
ribosylation, which to date have not been as extensively studied. All histones have been 
shown to be phosphorylated, and the phosphorylation of H1 and H3 has been linked to 
chromosome condensation and segregation (Guo et al., 1995). Additionally, in mammals, 
phosphorylated H3 correlates with transcriptional activation (Thomson et al., 1999). 
Ubiquitination occurs on lysine residues of at least H2A, H2B, H3 and H1 (Belz et al., 
2002). Active transcription has been associated with monoubiquitinated histones (Davie 
et al., 1991). ADP-ribosylation is achieved on all histones by poly-ADP-ribosylate 
protein 1 (PARP1) (de Murcia et al., 1988) and has been linked to aging, as the amount of 
ribosylated histones has been shown to decrease with age (Mishra and Das, 1992). 
 
DNA methylation occurs on cytosine residues on CpG islands and is catalyzed in 
mammals by DNA methyltransferases (DNMTs) Dnmt1, Dnmt1, Dnmt3a and Dnmt3b 
(reviewed in Svedruzic, 2008). The latter two DNMTs are involved in de novo 
methylation whereas Dnmt1, the most abundant of the three in mammalian cells, 
maintains methylation patterns on CpG dinucleotides during DNA replication (reviewed 
in Dhe-Paganon et al., 2011). Genome-scale DNA methylation maps and in silico 
prediction studies suggest that the majority of the mammalian genome is in fact 
methylated, with only 1-2% unmethylated domains consisting mostly of CpG islands, 
1000 bp long CG-rich stretches often occurring at promoters (Bird et al., 1985; Eckhardt 
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et al., 2006; Illingworth et al., 2008; Rabinowicz et al., 2003; Rakyan et al., 2004; Suzuki 
et al., 2007). Although the role of intragenic methylation is still unresolved, methylation 
at CpG islands of promoters is typically associated with transcriptional silencing 
(reviewed in Suzuki and Bird, 2008). Although typically DNA methylation has been 
thought of as a relatively stable, inherited form of repression, recent evidence 
demonstrated that certain promoters are methylated in a transient cyclical fashion with 
rapid kinetics, which directly influences RNAP II occupancy and transcription 
(Kangaspeska et al., 2008; Kim et al., 2009; Metivier et al., 2008). Dnmt1 deregulation as 
well as DNA hyper- and hypomethylation states have been associated with cellular 
differentiation as well as numerous diseases such as cancer and diabetes (reviewed in 
Dhe-Paganon et al., 2011).  
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II. Transcriptional regulation of energy metabolism 
 
Although almost all cells in the human body contains the same information within its 
DNA, over 250 different cell lineages exist with distinct morphologies, varying protein 
compositions and highly divergent functions. This fine-tuning of gene expression is 
achieved largely through RNAP II regulation by cell and stimuli-specific transcription 
factors as well as transcriptional co-activators, many of which contain enzymatic 
chromatin modifying activities described previously. One of the major challenges is the 
maintenance of energy balance, requiring constant attention of energy intake and energy 
expenditure in order to sustain homeostasis both in cells and tissues to avoid conditions 
such as obesity or the metabolic syndrome. Different cell types react in very diverse ways 
to alterations in metabolic state through regulating catabolic (breaking down) and 
anabolic (building up) metabolic pathways. Since the energy requirements of specific 
tissues within the body as well as in response to different external and nutritional stimuli 
differ greatly, energy metabolism is an excellent example of transcriptional regulation by 
specific transcription factors, co-activators and chromatin modifiers. 
 
The transcriptional cascade of adipocyte differentiation  
 
Two types of adipose tissue exist in mammals: brown adipose tissue (BAT) and white 
adipose tissue (WAT). WAT forms the main fat depots in the body, the subcutaneous and 
visceral fat, and serves as the major energy store for situations such as fasting, whereas 
BAT contains high amounts of mitochondria and less fat droplets and is largely absent 
from humans. For decades, adipose tissue was disregarded by scientists due to its 
apparent function mainly as an insulator, a storage of energy and cushion system of the 
body.  However, it is now recognized as an endocrine organ, secreting peptide hormones 
such as leptin and resistin along with fatty acids that, in addition to regulating appetite 
and energy metabolism, affect bone mass, heamatopoesis, and blood pressure (reviewed 
in Kershaw and Flier, 2004). With the explosion of obesity and related metabolic diseases 
such as type II diabetes within the last 30 years in the Western world, numerous scientists 
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have concentrated their efforts into understanding the adipose tissue and deciphering how 
cells differentiate into adipocytes. 
 
Differentiation of mesenchymal preadipocytes to mature adipocytes (adipogenesis) 
involves contact inhibition followed by hormonal stimuli such as insulin/IGF-1, which 
leads to the expression of key transcription factors, namely PPARγ, Krox-20 and 
CCAAT/enhanced binding proteins (C/EBPs) (Chen et al., 2005). Their expression 
coincides with two rounds of mitosis termed clonal expansion (Fajas et al., 2002; Lane et 
al., 1999; Tang et al., 2003). Following clonal expansion, the cells are committed to 
differentiate into adipocytes through the expression of adipogenic genes such as 
adiponectin, adipsin and aP-2, which result in the accumulation of lipids and eventually, 
in the fully differentiated adipocyte phenotype (reviewed in Rosen and MacDougald, 
2006). Relatively little is known about the differentiation of brown adipocytes, but 
PPARγ-coactivator-α (PGC1-α) appears to play a role in it. When PGC-1a is introduced 
in white adipocytes, they begin to resemble their brown counterparts; expression and 
activity of UCP-1, an enzyme specific for brown adipocytes, is increased and 
mitochondrial biogenesis initiated (Puigserver et al., 1998; Tiraby et al., 2003). The 
traditional view of the process of adipocyte differentiation is illustrated in Figure 5.  
 
The primary transcript of the PPARγ gene is alternatively spliced to encode three 
different protein isoforms: PPARγ1 which is ubiquitously expressed, PPARγ3 which 
dominates in the large intestine and PPARγ2 which is predominant in white adipose 
tissue (Braissant et al., 1996). PPARγ2 has been coined the master regulator of 
adipogenesis as it is both sufficient and essential for this process (Rosen et al., 1999; 
Tontonoz et al., 1994). Upon activation through binding of endogenous metabolites 
acting as ligands, it heterodimerizes with retinoid X receptor (RXR) and binds to PPAR 
response elements (PPREs) on target genes, thus initiating transcription (Chandra et al., 
2008).  PPARγ2 is a phosphoprotein that can be phosphorylated on S112 by mitogen-
activated protein kinase (MAPK) (Adams et al., 1997; Camp and Tafuri, 1997) and Cdk7 
in vitro (Compe et al., 2005). However, in contrast to activating phosphorylation 
observed in the majority of nuclear hormone receptors, the phosphorylation of PPARγ on 
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S112 inhibits its activity (Adams et al., 1997; Camp and Tafuri, 1997; Hu et al., 1996). 
Furthermore, mutated PPARγ-S112A in preadipocyes results in increased adipogenesis 
(Hu et al., 1996). In addition to ligand binding and phosphorylation, PPARγ activity is 
further regulated in some tissues by co-activators such as PGC-1 and SRC-1 (Puigserver 
et al., 1999).  
 
Figure 5. The process of adipocyte differentiation. Undifferentiated cells that have undergone growth 
arrest can differentiate into adipocytes upon induction by hormones or in response to external stimuli. The 
induced cells undergo clonal expansion, which commits them to the adipogenic lineage. Expression of 
adipogenic transcription factors results in the fully differentiated adipocyte characterized by large lipid 
vacuoles and increased mitochondria. PGC-1α expression directs the differetiation process towards brown 
adipocytes, which contain a higher amount of mitochondria and many small lipid droplets. The required 
adipogenic transcription factors are highlighted in red and placed at the differentiation stage when their 
expression peaks. 
 
PPARγ has attracted much clinical interest since it was identified to be the target of 
synthetic antidiabetic drugs called thiazolidinediones (TZDs) (Lehmann et al., 1995). 
TZDs exert their effect by reducing hyperlipidemia and insulin resistance (reviewed in 
Olefsky, 2000).  Paradoxially, they activate PPARγ and thus induce adipogenesis 
(Lehmann et al., 1995). Although the amount of adipocytes increases in response to TZD 
treatment, the size of the new adipocytes is smaller, they exhibit characertistics of brown 
adipocytes and appear to be metabolically more active, thereby potentially restoring the 
insulin sensitivity of fat (Wilson-Fritch et al., 2004; Yamauchi et al., 2001). In support of 
this, although PPARγ-S112A mice demonstrate an increased potential for adipogenesis, 
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they do not gain weight and show increased insulin sensitivity (Rangwala et al., 2003). 
Hence, it is now widely recognized that the regulation of PPARγ in vivo is more complex 
than previously thought and that it may be clinically beneficial to activate PPARγ more 
selectively through modulating its phosphorylation on S112 (reviewed in Cock et al., 
2004). 
 
The PPARγ co-activator-1 family members and fatty acid oxidation 
 
The PPARγ co-activator-1 (PGC-1) family members are transcriptional co-activators that 
bind to a myriad of transcription factors, increasing their ability to stimulate transcription 
of genes involved in glucose, lipid and energy homeostasis. The two major isoforms 
present in tissues with high energy requirements (heart, liver, skeletal muscle and brown 
fat) are PGC-1α and PGC-1β. Originally, PGC-1α was discovered as a thermogenic 
switch in brown fat, where it is required to stimulate fuel intake, fatty acid oxidation and 
heat production (Puigserver et al., 1998), but it is now recognized that dysregulation of 
these coactivators plays an important part in the development of pathophysiologies such 
as heart failure and diabetes (reviewed in Lin et al., 2005). 
 
PGC-1 co-activators facilitate the transcription of mitochondrial fatty acid oxidation 
(FAO) genes. These co-activators do not contain a DNA-binding domain, but are 
mobilized to target genes by tissue-specific transcription factors like PPARγ (brown fat) 
(Tiraby et al., 2003), muscle enhancer factor 2 (MEF2) (Handschin et al., 2003) and 
hepatocyte nuclear factor 4α  (HNF4α) (Rhee et al., 2006) or ubiquitous factors such as 
nuclear respiratory factors (NRFs) (Wu et al., 1999). In turn, they recruit chromatin-
modifying enzymes, for example HATs p300 and steroid receptor co-activator (SRC-1) 
(Puigserver et al., 1999) and the Mediator complex to initiate transcription (Wallberg et 
al., 2003). PGC-1 co-activators are themselves tightly regulated by environmental cues 
and nutritional stimuli. For example, strenuous exercise increases PGC-1α mRNA levels 
in skeletal muscle (Baar et al., 2002; Goto et al., 2000), and in brown fat PGC-1α mRNA 
is induced in response to cold exposure (Puigserver et al., 1998). 
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The heart is the largest consumer of energy in the body taking into account its size. The 
majority of ATP produced in the heart is a result of mitochondrial β-oxidation of fatty 
acids, with 5-10% coming from glycolysis. It is not surprising that due to its large 
consumption of ATP, both PGC-1α and PGC-1β are very highly expressed in the heart 
(Lin et al., 2002a; Puigserver et al., 1998). PGC-1α is especially important in the 
neonatal developing heart when the workload and energy requirement of the heart 
dramatically increase and a metabolic switch from glycolysis to fatty acid oxidation 
occurs (Lehman et al., 2000).  In the heart, PGC-1α promotes the transcription of genes 
required for mitochondrial biogenesis through direct interaction with NRFs and ERRs 
and of genes involved in fatty acid import and utilization through PPARα (reviewed in 
Rowe et al., 2010). In addition, PGC-1α activates a large array of angiogenic factors, 
including VEGF through ERRα (Arany et al., 2008), providing a link between high 
energy expenditure and the vasculature which supplies the heart with nutrients.  
 
The role of mitochondrial dysfunction in cardiomyopathy and heart failure is evident 
from genetic human diseases: over 50% of mitochondrial DNA mutations and most 
mutations of the nuclear-encoded genes for fatty acid oxidation and transport result in 
cardiomyopathy (reviewed in Rowe et al., 2010). Mouse models of cardiac dysfunction 
have suggested that PGC-1α would be at least one common culprit, as a number of these 
mice exhibit decreased expression of PGC-1α (Garnier et al., 2003; Palomer et al., 2009; 
Sano et al., 2004). Additionally, heart-specific PGC-1α knockout mice show decreased 
fatty acid oxidation, abnormal mitochondria, reduced ATP synthesis and eventually, at 
two months of age, cardiac failure (Arany et al., 2005; Arany et al., 2006; Lehman et al., 
2008). 
 
Transcriptional control of hepatic lipogenesis 
 
Mammalian lipid homeostasis is largely controlled by a family of membrane-bound 
transcription factors, the sterol regulatory binding-element proteins (SREBPs).  SREBPs 
exist as three isoforms generated from two genes; SREBP-1a and SREBP-1c encoded by 
the same gene but through utilization of a different transcription start site, and SREBP-2 
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(Sato). SREBP-1a is mainly expressed in cultured cells, SREBP-1c in hepatocytes and 
muscle and SREBP-2 ubiquitously in mammals (Shimomura et al., 1997). Transgenic and 
knockout mouse models of SREBPs have demonstrated that SREBP-1c is the chief 
regulator of lipogenesis in the liver (Shimano et al., 1997a; Shimomura et al., 1999; 
Shimomura et al., 1998; Tobe et al., 2001), whereas SREBP-2 governs cholesterol 
synthesis (Horton et al., 1998; Shimano et al., 1997b).  
 
 
Figure 6. Regulation of lipid and cholesterol metabolism by SREBPs. Acetyl CoA is produced from 
glycolysis of glucose in the mitochondria and used for synthesis of fatty acids or cholesterol. SREBP-1c 
regulates the transcription of the genes coding for the main enzymes required for the synthesis of 
triglycerides and phospholipids (depicted in grey). SREBP-2 regulates the expression of the genes involved 
in cholesterol synthesis. In addition, the main enzymes that catalyze the production of NADPH are encoded 
by SREBP-1c target genes. ACS; acetyl CoA synthase, ACL; acetyl CoA lyase, ACC; acetyl CoA 
carboxylase, FAS; fatty acid synthase, Elovl6: elongation of long chain fatty acids family member 6, 
SCD1; stearoyl CoA desaturase, GPAT; glycerol phosphate acyltransferase, DGAT; diacylglycerol 
acyltransferase, ME1; malic enzyme, G6PD; glucose-6-phosphate dehydrodenase, PGDH; 
phosphogluconate dehydrogenase. 
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As inactive precursors, SREBPs are bound to the endoplasmic reticulum. Upon stimulus 
such as increased cholesterol levels, the SREBP cleavage-activating protein SCAP 
transfers SREBP to the Golgi apparatus, where it is cleaved by Site-1 and Site-2 
proteases (Matsuda et al., 2001).  The processed and active SREBPs are transported to 
the nucleus where they can bind to sterol regulatory elements (SREs) in promoters of 
target genes. These genes include all the main enzymes of the fatty acid biosynthetic 
pathways depicted in Figure 6, including ACC1, ACLY, FAS, G6PD, GPAT, and SCD1 
(Shimomura et al., 1998). 
 
Hepatosteatosis is the accumulation of triglycerides in the liver. It can exist as a benign, 
non-inflammatory form or progress on to steatohepatitis with strong inflammation, cell 
death and fibrosis. Insulin resistance, a characteristic of type II diabetic patients, is the 
most common metabolic problem associated with hepatosteatosis. In the classic model, 
insulin-resistant adipocytes increase their secretion of fatty acids, which are then taken up 
by hepatocytes, resulting in accumulation of fat in the liver (reviewed in Browning and 
Horton, 2004). Findings in the last decade also point towards a de novo pathway of 
hepatosteatosis formation, where increased synthesis of fatty acids in the liver takes place 
due to transcriptional activation of lipogenic SREBP-1c target genes (Shimomura et al., 
1999). For example, transgenic mice that overexpress SREBP-1c in the liver develop a 
classic fatty liver due to activation of lipogenic genes (Shimano et al., 1997a). Likewise, 
absence of SREBP-1c ameliorates the fatty liver phenotype of diabetic leptin receptor 
knockout mice (Yahagi et al., 2002). In addition to the well-documented role of SREBP1 
in hepatosteatosis, the carbohydrate response element binding protein (ChREBP) and 
PPARγ have been shown to participate in the formation of fatty liver (Iizuka et al., 2004; 
Kim et al., 1998), although these molecular pathways have not been fully defined. 
Importantly, PPARγ has been suggested to function downstream of SREBP-1c, as 
SREBP-1c can transcriptionally activate PPARγ (Fajas et al., 1999; Kim et al., 1998) 
 
Although PPARγ, PGC-1 and SREBP1 have been discussed here in a rather tissue-
specific context for structural purposes of the thesis, it is important to note that in some 
tissues as well as cell culture and disease models, they in fact co-operate to promote the 
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transcription of lipogenic, adipogenic and FAO genes. In addition, in some models they 
induce the expression of one another and also regulate each other via 
feedback/feedforward loops. Novel concepts as well as potential caveats that have risen 
during the thesis work will be elaborated on in ‘Discussion and Perspectives’. 
 
 
 
TFIIH: Linking general and gene-specific transcription 
 
In addition to its role as a general transcription factor, TFIIH has been implicated as a 
regulator of specific transcription factors, in particular the nuclear hormone receptors. 
Nuclear hormone receptors (NHRs) include androgen receptor (AR), progesterone 
receptor (PR), glucocorticoid receptor (GR), estrogen receptors α and β (ER) as well as 
the non-steroid receptors retinoid acid receptors (RARs), peroxisome proliferator-
activated receptors (PPARs) and vitamin D receptor (VDR). All NHRs are structurally 
similar within the C-terminal domain: they all contain a ligand-binding domain (LBD), 
which encompasses a ligand-dependent transactivation domain (AF-2) followed by a 
DNA binding domain (DBD). The A/B domain of the N-terminal region on the other 
hand is highly variable both in length and sequence (reviewed in Rochette-Egly, 2003). 
 
In the absence of a ligand, nuclear hormone receptors are inactive and typically bound by 
chaperone proteins. Upon ligand binding, they dissociate from the chaperones, dimerize 
and translocate to the nucleus where they bind response elements on the DNA of their 
target genes. Binding to the response elements brings the receptors to the vicinity of 
TFIIH: appropriately, Cdk7 has been identified to phosphorylate a number of these 
receptors on their A/B domain. In addition to the previously described PPARγ, these 
include PPARα, retinoic acid receptors α and γ and estrogen receptor α (Bastien et al., 
2000; Chen et al., 2000; Compe et al., 2005; Keriel et al., 2002; Rochette-Egly et al., 
1997). Many of the nuclear hormone receptors have additionally been shown to be 
phosphorylated by other kinases such as MAPK, Akt, PKC, PKA and JNKs (reviewed in 
Rochette-Egly, 2003). 
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In addition to regulating nuclear hormone receptors, TFIIH has been implicated in the 
phosphorylation of various other transcription factors. TFIIH enhances the binding of 
tumor suppressor p53 to DNA through phosphorylation (Ko et al., 1997; Lu et al., 1997). 
Cdk7 is able to directly phosphorylate elongation factors Cdk11 and Spt5 (Larochelle et 
al., 2006), Cdk5 (Rosales et al., 2003) and the octamer binding transcription factor Oct-1 
(Inamoto et al., 1997). These data imply that TFIIH may have more specific, regulatory 
roles in different tissues, cell-types or in response to certain stimuli and that this protein 
complex could serve as a link between general and gene-specific transcription initiation. 
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AIMS OF THE STUDY 
 
This study was undertaken to study the role of the mammalian TFIIH kinase complex and 
in particular the Mat1 subunit in the regulation of general and gene-specific transcription 
of RNA Polymerase II transcribed genes. The work utilizes the Cre-LoxP system to 
conditionally delete Mat1 in various tissues in vivo and as well as in cell culture models.  
 
Specific aims of the study were to characterize: 
 
I. Investigate the possible general role of the mammalian TFIIH kinase in RNA 
Polymerase II C-terminal domain phosphorylation, transcription and co-transcriptional 
processes. 
  
II. Idenfity and characterize possible gene-specific and tissue-specific functions for the 
TFIIH kinase using conditional deletion of the Mat1 subunit during adipocyte 
differentiation in vitro, and in cardiomyocytes and hepatocytes in vivo. 
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MATERIALS AND METHODS 
 
The materials and methods used in this study are listed below and are described in detail 
in the original publications, which are here referred to using Roman numerals. 
 
1.Materials 
 
Mouse lines  Description   Source or reference  Used in 
αMHC-Cre  cardiac-specific Cre, expressed  
under myosin heavy chain  
promoter   Gaussin et al, 2002  III 
C57BL/6J-Tg(Mx1-cre) liver-specific Cre, expressed 
under Mx1 promoter    JAX Laboratories  IV 
Mat1 flox  Mat1 allele with loxP sites, 
deletion inducible by Cre  Korsisaari et al, 2002  I-IV 
 
 
Cells   Description   Source or reference  Used in 
Primary MEFs  mouse embryonic fibrobasts prepared by author  I-III 
Immortalized MEFs MEF cell line immortalized  
with Retro-p53   prepared by author  I-II 
HepG2   human hepatocarcinoma  ATCC 
cell line        IV 
3T3-L1   mouse preadipocyte cell line ATCC    II 
Phoenix 293T   human embryonic kidney ATCC 
cell line        II 
  
 
Plasmids/constructs Description   Source or reference  Used in 
GST-CTD  triple repeat of RNAPII CTD 
fused to GST   provided by Dr. Young  II 
GST-Cdk2  Cdk2 fused to GST  provided by Dr. Young  II 
PPRE3-TK-Luc  3 x PPRE fused to luciferase provided by Dr.  
Chatterjee   II 
pCMV-SPORT6- 
PPARγ2  PPARγ2 expressed under  
CMV promoter   MGC Gene collection  II 
pSV-SPORT- 
PPARγS112A  non-phosphorylated PPARγ2 
   mutant    provided by Dr. 
Spiegelman   II 
 
 
Antigens (Name)  Description   Source or reference  Used in 
Actin (AC-40)  rabbit polyclonal ab  Sigma    I-IV 
BrdU (BU33)  mouse monoclonal ab  Dako    II, III 
Cdc2-T161-P (9114) rabbit polyclonal ab  Cell Signaling   II 
Cdk2-T160-P (2561) rabbit polyclonal ab  Cell Signaling   II 
Cdk2 (sc-163)  rabbit polyclonal ab  Santa Cruz   II 
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Cdk7 (C-4)  mouse monoclonal ab  Santa Cruz   I-IV 
C/EBPβ (ab15049) mouse monoclonal ab  Abcam    II 
DMAP1 (ab2848) rabbit polyclonal ab  Abcam    IV 
Dnmt1 (ab13537) mouse monoclonal  Abcam    IV 
Mat1 (FL-309)  rabbit polyclonal ab  Santa Cruz   I-IV 
m7G-cap (K121) mouse monoclonal ab  Calbiochem   I 
catalase (ab1877) rabbit polyclonal ab  Abcam    I, IV 
p44   rabbit polyclonal ab  Genway   I 
p62   rabbit polyclonal ab  Genway   I 
PPARg (ab41928) mouse monoclonal ab  Abcam    II 
PPARg-S112-P (IF5) mouse monoclonal ab  Euromedex   II 
PGC-1   rabbit polyclonal ab  US Biologicals   III 
RNAPII (N20)  rabbit polyclonal ab  Santa Cruz   I,III,IV 
RNAPII-S2 (H5) mouse monoclonal ab  Nordic Biosite   I, III 
RNAPII-S5 (H14) mouse monoclonal ab  Nordic Biosite   I, III 
RNAPII-S5 (ab5131) rabbit polyclonal ab  Abcam    I 
SREBP-1 (ab28481) rabbit polyclonal ab  Abcam    IV 
TAF10   mouse monoclonal ab  provided by Dr. Tora  II 
XPD   mouse monoclonal ab  provided by Dr. Egly  I 
 
 
Viruses Description    Source or reference  Used in 
AdCre  encodes Cre recombinase  provided by Dr. Parada  I, II, III  
AdGFP  encodes GFP    provided by Dr. Parada  II 
AdLacZ encodes LacZ    provided by Dr. Zhu  I, II, III 
Retro-p53 encodes CTD of p53   provided by Dr. Klefstrom II 
Retro-Mat1 encodes Mat1    Biomedicum Virus Core II 
 
 
siRNA/shRNA  Description   Source or reference  Used in 
shRNA-K7/pENTR-H1 short hairpin RNA towards  
human Cdk7   prepared in Mäkelä lab  II 
shControl/pENTR-H1 short nontargeting RNA  prepared in Mäkelä lab  II 
siMat1 (mouse) Mat1 targeting oligos:  
L-047470-00-0005  Dharmacon   III 
siMat1 (human)  Mat1 targeting oligos: 
L-003281-00-0005  Dharmacon   IV 
siDMAP1 (human) DMAP1 targeting oligos: 
   D-001810-10-05  Dharmacon   IV 
siSREBP-1 (human) SREBP-1 targeting oligos: 
L-006891-00-0005  Dharmacon   IV 
siNONTARGETTING nontargeting oligos: 
   D-001810-10-20  Dharmacon   I, II, IV 
 
2. Methods 
 
Method         Used in 
Adenoviral infection        I-III 
Adenovirus production        I-III 
Adipocyte differentiation       II 
Affymetrix expression profiling       I, III 
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BrdU labeling         II 
Cell culture         I-IV 
Chromatin immunoprecipitation (ChIP)      I, IV 
Flow cytometry analysis       III 
Generation of immortalized MEFs      II 
Glucose and fatty acid oxidation  assay      I 
GST-pulldown         II, III 
Immunofluorescence analysis (IF)      I-III 
Immunohistochemistry (IHC)       I, III, IV 
Immunoprecipitation        I-III 
Isolation of primary MEFs       I-III 
Luciferase reporter assay       I-III 
In vitro kinase assay        I, II 
Microscopy         I-IV 
Mitochondrial enzyme and respiration assays     III 
Methyl-cap mRNA IP        I 
Mouse breeding /crossing       II-IV 
Nascent mRNA analysis with FU labeling     I 
Nascent mRNA analysis with EU labeling     I 
Real-time quantitative PCR       I-IV 
Retroviral transduction        II 
RNA extraction         I-IV 
siRNA knockdown        I, II, IV 
Splicing analysis        I 
Oil RedO staining        II 
Poly(A) mRNA IP        I 
pI-pC mouse injections        IV 
Transfection of cells         I-IV 
Triglyceride assay        IV 
Western blot analysis        I-IV
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Methods 
 
The following section describes in detail the main methods used by the author. 
 
Adipocyte differentiation of MEFs and 3T3-L1 cells (II) 
Two-day post-confluent MEFs or 3T3-L1 preadipocytes were treated with differentiation 
medium (Dulbecco’s modified Eagle medium with 10% calf serum supplemented with 10 
µg/insulin, 1 µM dexamethasone, 0.25 mM 3-isobutyl-1-methylxanthine) for 2 days, 
followed by 2 days of insulin-supplemented medium, followed by 4 days in normal 
growth medium. For analysis of lipids, cells were fixed after the differentiation protocol 
with 10% formalin for 30 min at +37°C and stained with Oil Red O (Sigma).  
 
Gene expression profiling and data analysis (I, III) 
mRNAs were collected from tissues or cells using RNEasy Kit (Qiagen). cDNA synthesis 
using oligo dT primers, target labeling, and hybridization were done using Affymetrix 
GeneChip Reagents according to manufacturer’s protocol using Affymetrix high-density 
Mouse Genome 430 2.0 Arrays, and scanned with an Agilent microarray laser scanner. 
Data from all arrays has been deposited at ArrayExpress (www.ebi.ac.uk/microarray-
as/ae/). Data analysis and comparison of the data set to other published microarray 
studies were performed using GeneSpring GX (Agilent Technologies), Microsoft Excel, 
and Filemaker Pro software. For standard comparison of differentially regulated genes at 
a given time point samples arranged by genotype were filtered for expression (at least 1/6 
raw values between 20-100% percentile for inclusion), for significance (paired T-test, 
p<0.05) and fold change (>1.5). For analysis of general changes in signal intensities in 
MEFs (I), a normalization between genotypes at the 72 h time point was performed using 
a normalization factor generated through pairwise comparisons of triplicate averages of 
45 Probe Sets: AFFX labeling controls (28 probes), AFFX prelabeled hybridization 
controls (excluding AFFX-Cre due to the Adeno-CRE infection; 14 probes) and AFFX 
mouse non-PolII/PolI controls (3 probes) leading to a normalization factor of 1.0374 for 
Mat1-/- samples. 
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Analysis of capped, FU labeled and EU labeled transcripts (I) 
Capped and methylated mRNAs were immunoprecipitated from total RNA using α-m7G-
cap antibody (H20; K121 Calbiochem) in cap binding buffer (150 mM NaCl, 0.1% NP-
40, 10 mM Tris, pH 8.0) and kept on ice for 1 h. After this, the samples were incubated 
overnight at + 4°C with 100 µl of Protein A Sepharose beads + 5 µl DTT + 1.25 µl 
RNAseOUT. The following day, the samples were washed five times with ice-cold 
binding buffer containing 2.5 mM DTT, beads were resuspended in 200 µl of ProtK 
solution and nutated at + 37°C for 30 min. The precipitated RNA was purified, measured 
and calculated as % of input RNA. Immunoprecipiated material was additionally 
analyzed with qRT-PCR. 
For 5-Flourouridine (FU) experiments, cells were pulsed with 1 mM FU in KH buffer (30 
mM KCl, 10 mM HEPES pH 7.4) for 10 min and pulse-chased for various times. 
Immunoprecipiattion was performed using α-BrdU (DAKO), otherwise following the 
same protocol as for the capping analysis described above. Immunoprecipitated material 
was additionally analyzed with qRT-PCR. 
5-Ethinyl uridine (EU) labeling experiments were done according to the protocol of 
Click-iT Nascent RNA Capture kit (Invitrogen). Briefly, cells were pulsed with 0.5 mM 
EU, total RNA was isolated, and used in a copper catalyzed click reaction with azide-
modified biotin. The nascent transcripts were captured using streptavidin magnetic beads. 
cDNA synthesis was performed using the immunoprecipitated material directly on the 
beads using Superscript VILO cDNA synthesis kit (Invitrogen) followed by analysis with 
qRT-PCR. 
 
Chromatin immunoprecipitation (I, IV) 
For chromatin immunoprecipitation of cells (ChIP) 5-10 x 106 cells were cross-linked 
with 1% paraformaldehyde (PFA) for 10 minutes at room temperature. The cross-linking 
reaction was terminated with glycine and cross-linked cells washed 3 x with phosphate 
buffered saline (PBS). For ChIPs from tissues, 15-30 mg liver pieces were cut into 1 mm2 
pieces and fixed with 1% PFA for 15 minutes at room temperature, terminated with 
glycine and samples washed 3 x 5 minutes with PBS. Fixed tissues were lysed with 
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Lysing Matrix D beads using Precellys-24 and sonicated. Immunoprecipitation was 
performed using 5-10 µg of antibodies described in Materials in rotation overnight in + 
4°C. Binding was performed for 3 hours at + 4°C with 50% slurry protein-A sepharose 
(PAS) followed by washes once with low salt buffer (20 mM Tris-HCl pH8.0, 150 mM 
NaCl, 2 mM EDTA, 1% Triton-X100, 0.1% SDS), 3 times in high salt buffer (20 mM 
Tris-HCl pH8.0, 500 mM NaCl, 2 mM EDTA, 1% Triton-X100, 0.1% SDS), once in 
LiCl containing buffer (10 mM Tris-HCl pH8.0, 250 mM LiCl, 1 mM EDTA, 1% DOC, 
1% NP-40) and twice with TE, pH 8.0. Elution of precipitated proteins was performed 
using elution buffer (0.1 M NaHCO3, 1% SDS) containing 50 µg of proteinase K 
(Fermentas) at + 42°C for 45 min. Reverse cross-linking of precipitated chromatin was 
done at + 67°C overnight with NaCl solution to 200 mM final concentration. Controls: 
antibodies: rabbit IgG and peroxisomal α−catalase (ab1877), negative genomic region: 
SBiosciences intergenic negative control primers. The ChIP samples were purified using 
QIAquick PCR purification kit spin columns (Qiagen) and eluted twice in 10 mM Tris-
HCl pH8.5 buffer. Immunprecipitated material was analyzed with qRT-PCR, normalized 
to IgG/control antibody and calculated as % input. 
 
Generation of immortal Mat1-/flox MEFs (I-III) 
MEFs were isolated from E12.5 Mat1-/flox embryos and cultured in DMEM (Gibco) 
supplemented with 10% fetal calf serum and antibiotics. Immortal Mat1-/flox MEFs were 
generated by infecting cells from passage 3 with a retrovirus encoding residues 302 to 
309 of p53 (Klefstrom, J et al, 1997) and selected with hygromycin (Invitrogen). For 
deletion of Mat1, MEFs were infected with adenoviruses encoding CRE-recombinase 
(AdCre) or LacZ (AdLacZ) or GFP (AdGFP) using multiplicity of infection of 1500  
overnight at 37 °C.  
 
Immunostaining of murine tissue and cultured cells (I-IV) 
For paraffin and frozen sections, mice were fixed using intracardiac perfusion with 1% 
PFA under anesthesia. Tissue sections were washed with PBS, permeabilized using 0.3% 
PBS-Triton X (Fluka Biochemicals) and blocked with PBS containing 5% donkey serum, 
0.05% sodium azide, 0.2% bovine albumin serum, and 0.3% Triton X. The tissue slides 
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were incubated with antibodies described in Materials diluted in blocking solution 
overnight, followed by incubation with secondary antibodies. Nuclei were stained with 
DAPI. Immunofluorescence samples were mounted with Vectashield mounting medium 
(H-1200, Vector).  
For immunostaining of cells, cells were grown on coverslips, fixed with 3.5% PFA 15 
min and washed with PBS. Fixed cells were permeabilized with PBS-0.25% Triton X for 
10 min and blocked with PBS-0.25% Triton X-5% normal goat serum for 20 min. Cells 
were incubated with primary antibodies listed in Materials diluted in blocking solution 
for 1 h at room temperature, and with secondary antibodies diluted in blocking buffer for 
30 min at room temperature. Nuclei were stained with Hoechst and coverslips mounted 
with Elvanol.  
Tissue samples were analyzed with a confocal microscope (Zeiss LSM 510; Carl Zeiss) 
and cell samples using Zeiss Axioplan 2 microscope and Axiovision software.  
 
Quantitative real time PCR (qRT-PCR) analysis of mRNA levels (I-IV) 
RNA was isolated using RNEasy isolation kit (Qiagen) according to the manufacturer’s 
protocol. Double-stranded complementary DNA was amplified using Power SYBR 
Green PCR Master Mix (Applied Biostystems). Relative mRNA amounts were assayed 
by normalizing PCR cycles to GAPDH for each sample unless otherwise indicated using 
7500 Fast Real-Time PCR System Software or BioStep1 plus RT-PCR Software 
(Applied Biosystems). Technical triplicates were run from 3-7 independent experiments 
in all cases. 
 
Transfections and cell treatments (I-IV) 
For siRNA knockdown experiments, Mat1-/flox MEFs were transfected with 100 nmol 
siRNA diluted in OptiMEM (Gibco) and incubated with Lipofectamine 2000 (Invitrogen) 
following the manufacturer's instructions. Transfections were repeated 24 h later. RNA 
was collected 72 h from first transfection. siRNAs used are listed in the Materials chart. 
For reporter gene assays, the Luciferase constructs desrcribed in Materials were 
transfected transiently using Superfect transfection reagent (Qiagen) or Effectene 
(Qiagen) according to manufacturer’s instructions. Troglitazone treatment of MEFs 
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(Cayman Chemical Company) was done at 10 µM from 4-24 h. 5-Aza-cytidine (Sigma) 
treatment of HepG2 cells was with 10 µΜ for 48 h.  
 
Triglyceride analysis 
Homogenization of 15-30 mg of liver was done in 10% Tween-H2O with Precellys-24 
machine (Bertin Technologies) at settings 5000, 2 x 20 sec, after which the samples were 
incubated in +70C for 5 min. After centrifugation at 5000 rpm for 1 min, the supernatant 
was collected into a new tube and centrifuged again at 14,000 rpm for 3 minutes. 
Triglycerides were measured from the supernatant using Triglyceride kit 
(ThermoScientific) at OD520 and calculated as ratio to protein from the same supernatant.   
 
Western blotting and kinase assays 
For Western blotting analysis of proteins MEFs were lysed in Laemmli sample buffer and 
centrifuged at 13 000 rpm for 15 min. Cleared samples were run in SDS-polyacrylamide 
gels and blotted onto nitrocellulose membranes (Protran) using either wet blotting 
overnight (Applied Biosystems) or semi-dry blotting for 1.5 h (Owl Scientific). 
Membranes were incubated with antibodies from Materials overnight in 5% milk-PBS, 
detected with secondary antibodies visualized with ECL reagent (Thermo Scientific).  
For in vitro kinase assays, freshly prepared cell lysates were immunoprecipitated with 
α−Cdk7 and 50% PAS slurry for 1.5 h in + 4°C. Kinase activity of immunoprecipitates 
was measured against in vitro GST substrates described in Materials in the presence of 20 
µCi γ-32PATP in 20 mM Tris-HCL, pH 7.5, 50 mM KCl, 5 mM MgCl2 with 2.5 mM 
MnCl2 and 1 mM DTT. Samples were resolved in SDS-polyacrylamide gels and detected 
with autoradiography. 
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RESULTS  
 
1. Mat1 is required for phosphorylation of RNA Polymerase II C-terminal domain, 
transcription and efficient mRNA turnover (I) 
  
The contradictory evidence from different model organisms concerning the in vivo RNAP 
II CTD Ser5 kinase and the role of TFIIH in transcription prompted us to undertake a 
study of global transcriptional effects following temporal deletion of the Mat1 subunit of 
TFIIH in mouse embryonic fibroblasts (MEFs). This was achieved by expressing Cre 
recombinase through adenoviral infection in MEFs carrying a floxed Mat1 allele 
(Korsisaari et al., 2002).  Within 48 h following AdCre infection, Mat1 as well as Cdk7 
protein levels were undetectable by Western blot, and at 72 h, phosphorylation of both 
Ser5 and Ser2 of RNAP II CTD were dramatically reduced at global levels (down to 17% 
and 21%, respectively). In addition, Ser5-P was decreased to 10-25% both at the TSS and 
in gene bodies of all analyzed genes (Bact, Rab2b, Rpl30, Tuba4). These results 
demonstrate that Mat1 is required for phosphorylation of RNAP II CTD and strongly 
suggest that Cdk7 is the mammalian kinase responsible for this activity.  
 
Global gene expression profiling of steady-state mRNAs revealed that although Mat1-/- 
MEFs showed a small but significant general decrease in mRNA expression, the majority 
of mRNAs remained unchanged.  However, chromatin immunoprecipitation (ChIP) 
experiments demonstrated that RNAP II levels were decreased in the bodies of all genes 
analyzed independent of whether their steady-state levels were decreased, increased or 
unchanged. This suggested a global defect in the progression of RNAP II into elongation, 
which would not be reflected on the steady-state levels of most mRNAs. Defective 
transcription was also supported by analysis of c-Fos mRNA levels after serum 
stimulation as well as Hsp70 mRNA levels following heat shock: in both induction 
models, Mat1-/- MEFs demonstrated deficient and delayed accumulation of the analyzed 
mRNAs. Analysis of nascent transcripts using two alternative methods of in vivo RNA 
labeling revealed a global defect in transcription following Mat1 deletion: a pulse-chase 
of 1 h demonstrated a global decrease in labeled RNA as well as a decrease of all 
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analyzed mRNAs in Mat1-/- MEFs. A time-course labeling experiment analyzing three 
genes with unchanged steady-state mRNAs (c-Myc, Pim1 and Gapdh) showed that the 
labeled mRNA persisted for a much longer time in the Mat1-deleted cells, conveying 
altered mRNA turnover and increased mRNA half-life following the transcriptional 
attenuation in these cells. 
 
In addition to the global defect in RNAP II progression into elongation, analysis of 5’end 
capping and splicing of both U2- and U12-type introns demonstrated reduced levels of 
both capped and spliced transcripts.   These findings are in concert with those from other 
models (Bird et al., 2004; Cho et al., 1997; Glover-Cutter et al., 2008; McCracken et al., 
1997a; McCracken et al., 1997b; Mortillaro et al., 1996; Moteki and Price, 2002; 
Viladevall et al., 2009) and suggest that transcription and mRNA processing events in 
mammalian cells would progress much in the same way as in yeast: TFIIH 
phosphorylates Ser5 needed for the recruitement of capping enzymes, which in turn 
recruit Cdk9, thus resulting in Ser2 phosphorylation and transcription elongation 
(Guiguen et al., 2007; Pei et al., 2003; Qiu et al., 2009). The results demonstrate that 
mammalian Mat1 is required for global transcription and efficient capping and suggest 
that this requirement is mediated via phosphorylation of the Pol II CTD on Ser5. 
Furthermore, the results reveal an unprecedented stabilization of mRNAs following 
transcriptional attenuation. 
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2. The Cdk7 kinase submodule of TFIIH acts as a physiological roadblock to 
adipogenesis through inhibitory phosphorylation of PPARγ  (II) 
 
As part of characterizing the functions of the kinase submodule of TFIIH, different 
tissues were assessed for the protein levels of Cdk7 and Mat1. Unexpectedly, we 
discovered that white adipose tissue exhibited very low levels of these subunits of TFIIH. 
This was an unexpected finding, as Mat1 and Cdk7 had been postulated as ubiquitous 
proteins. Since both subunits are expressed in undifferentiated fibroblasts, this suggested 
that these proteins may be downregulated during the process of adipocyte differentiation. 
Differentiation of 3T3-L1 fibroblasts into adipocytes demonstrated that indeed, both 
Mat1 and Cdk7 protein levels decreased progressively during adipogenesis. To further 
characterize the role of this kinase complex in adipogenesis, both a transient knockdown 
approach (siRNA and shRNA targeting Cdk7) and a conditional genetic deletion model 
(Mat1-/- MEFs) were used to assess the adipogenic role of Mat1 and Cdk7. Interestingly, 
fibroblasts with a deficient kinase submodule demonstrated an increased capacity for 
adipogenesis, increased activation of PPARγ as assessed by luciferase reporter assays and 
induced transcription of endogenous PPARγ target genes. These phenotypes were rescued 
by re-expression of Mat1, demonstrating that the intact kinase complex blocked PPARγ 
activity. 
 
As Cdk7 had been shown to phosphorylate PPARγ in vitro on Serine-112 (Ser112) 
(Compe et al., 2005), and this phosphorylation had been demonstrated to inhibit the 
activity of PPARγ (Hu et al., 1996), Ser112 phosphorylation was the most likely 
hypothesis for the mode of action of the Cdk7 kinase. To test this model, Mat1-/- MEFs 
and shCdk7 U2Os cells were transfected with PPARγ and stained for both total PPARγ as 
well as the Ser112 phosphorylated form. Although the levels of total PPARγ were 
identical to wild-type cells, both cell types with deficient Cdk7 kinase were unable to 
generate the Ser112 phosphorylated form of PPARγ, confirming that intact Cdk7 kinase 
activity is crucial for Ser112 phosphorylation of PPARγ. To directly assess the role of 
Ser112 phosphorylation in the acquired responsiveness to PPARγ in Cdk7 knockdown 
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models, MEFs were transfected with a nonphosphorylatable PPARγ mutant, PPARγ-
Ser112A. This mutant did not result in a similar increase in luciferase reporter activity as 
the wild-type PPARγ, demonstrating that the increased adipogenic potential noted in 
Cdk7-kinase deficient cells is mediated via inhibitory phosphorylation of PPARγ on 
Ser112. These results show that both Mat1 and Cdk7 proteins are decreased during 
adipogenesis and undetectable in mature, fully differentiated adipocytes, and that this 
kinase complex is required for the phosphorylation of PPARγ on Ser112. Thus they 
support a model where the Cdk7 kinase complex maintains cells in an undifferentiated 
state through the inhibitory Ser112 phopshorylation of PPARγ and suggest that in some 
circumstances, for e.g. adipocyte differentiation, the downregulation of this complex is 
required to surpass a roadblock to differentiation. 
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3. Mat1 is critical for cardiac energy metabolism in vivo via regulation of PGC1 (III) 
 
Previous findings had demonstrated that the Cdk7/CycH/Mat1 complex becomes 
activated in human heart failure and in mice with chronic cardiac hypertrophy (Sano et 
al., 2002). In order to further characterize the potential role of this complex in the heart, 
cardiac-specific Mat1 knockout mice were generated by crossing Mat1 flox mice 
(Korsisaari et al., 2002) with mice expressing the Cre recombinase under cardiomyocyte-
specific α–myosin heavy chain (αMHC) promoter (Gaussin et al., 2002),  (referred to in 
text as CKO). The hearts of Mat1 CKO mice developed normally and did not show 
defects in phosphorylation of Cdk2, Cdc2 or RNAP II despite reduced levels of Mat1, 
Cdk7 and CycH.   
 
Within 5-6 weeks, Mat1 CKO mice began to show signs of cardiomyopathy as evidenced 
by increased apoptosis of cardiomyocytes, systemic edema, ventricular dilation and 
fibrosis. All Mat1-/- mice died within 8 weeks as a result of cardiac failure. The fact that 
Mat1-deficient hearts developed normally for the first month suggested that the lethal 
cardiac phenotype was due to specific transcriptional changes. To investigate this, global 
gene expression profiling (Affymetrix) was performed from hearts of 4 week old mice. 
mRNAs involved in mitochondrial fatty acid β-oxidation, the tricarboxylic acid cycle and 
the respiratory chain were found to be downregulated in Mat1 CKO hearts compared to 
control littermates. Many of these mRNAs are regulated by the transcriptional co-
activator PGC-1α, which suggested that Mat1 deletion may be required for PGC-1 
mediated transcriptional activation. Indeed, PGC-1α failed to activate two well-
characterized target genes Atp5b and Cycs in Mat1-/- MEFs and deletion of Mat1 
suppressed the co-activation of PPARα and ERRα by PGC-1 in MEFs. Finally, a direct 
interaction between PGC-1α and both Mat1 and Cdk7 was detected, suggesting that the 
Cdk7/CycH/Mat1 complex may be involved in recruiting PGC-1 to target gene 
promoters, and hence be required for transcription of PGC-1 downstreatm targets. 
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4. Hepatic-specific deletion of Mat1 in mice results in fatty liver through induction 
of SREBP-1c target genes via loss of DMAP1 and Dnmt1 (IV) 
 
This study was undertaken to study the role of the Cdk7 kinase complex in hepatic lipid 
metabolism. Liver-specific conditional Mat1 knockout mice were generated by breeding 
Mat1 flox mice (Korsisaari et al., 2002) with interferon-response sensitive Mx1-Cre 
deletor mice (Kuhn, R. et al, 1995) which can be strongly induced in the liver following 
polyinosinic-polycytidylic acid (pI-pC) injections. Induction of Mx1-Cre was achieved 
using 3 consecutive injections of (pI-pC) every third day, and depletion of Mat1 protein 
levels was observed at day 14 from the first injection. At this timepoint, livers of Mx1-
Cre;Mat1-/-  mice displayed significant accumulation of triglycerides characteristic of 
hepatosteatosis. As Mat1 deletion in MEFs results in adipogenesis through activation of 
the PPARγ pathway (II), PPARγ as well as PPARα (the major PPAR isoform in liver), 
target gene expression was analyzed using qRT-PCR but the results did not indicate 
detectable alterations. Furthermore, levels of mRNAs that were identified to be 
dysregulated at the steady-state level following Mat1 deletion in MEFs were also 
quantitated but no significant differences were found, demonstrating that in different cell 
types, Mat1 regulates the steady-state levels of different mRNAs. 
 
SREBP-1c is the key transcription factor in regulating hepatic lipid metabolism 
(Shimomura et al., 1998) and as been shown to be involved in the development of fatty 
liver in response to insulin (reviewed in Foufelle and Ferre, 2002). Therefore, the levels 
of SREBP-1c target gene mRNAs were quantitated using qRT-PCR, and found to be 
paradoxically upregulated in livers of Mx1-Cre;Mat1-/-  mice compared to healthy 
littermates. This indicated that deletion of Mat1 in mouse hepatocytes results in 
triglyceride synthesis and accumulation due to induction of the lipogenic SREBP-1c 
downstream genes. A similar response was noted in cultured HepG2 hepatocarcinoma 
cells, where acute depletion of Mat1 using siRNA knockdown led to the increase in the 
levels of SREBP-1c target gene mRNAs. This induction requires SREBP-1, as following 
SREBP-11 knockdown no increase was noted. However, the induction of SREBP-1c 
target mRNAs was apparently not due to increased levels of SREBP1 based on 
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unchanged mRNA levels, suggesting an alternative transcriptional regulatory mechanism 
involving Mat1 and yet specific for SREBP-1c downstream geens.  
 
The finding that Mat1 deletion resulted in upregulation of specific mRNAs was 
surprising, since the majority of Mat1 functions have pointed to an activating role in 
transcription. However, Mat1 has been shown to bind to DMAP1 (Kang et al., 2007), a 
transcriptional co-repressor, which acts partially by recruiting DNA methyltransferase 1 
(Dnmt1) to DNA (Lee et al., 2010). To investigate whether this mechanism might 
underlie the increased SREBP-1c target mRNAs following Mat1 deletion, DMAP1 levels 
were downregulated using siRNA, and Dnmt1 activity inhibited with 5-Azacytidine in 
HepG2 cells. Remarkably, both of these treatments resulted in specific upregulation of 
SREBP-1c target gene mRNAs. Furthermore, double knockdowns of Mat1 and DMAP1 
together or in combination with Dnmt1 inhibition did not have additive effects on the 
increased levels of SREBP-1c target gene mRNAs. This data indicated that Mat1, 
DMAP1 and Dnmt1 collaborate to maintain appropriate levels of SREBP-1c lipogenic 
mRNAs in healthy hepatocytes by suppressing transcription through the DNA 
methyltransferase activity of Dnmt1. 
 
To investigate whether DMAP1 and Dnmt1 occupy the promoters of repressed SREBP-
1c target genes and whether their presence is dependent on Mat1, chromatin 
immunoprecipitations (ChIP) with Mat1, DMAP1 and Dnmt1 were performed from 
livers of Mx1-Cre;Mat1-/- mice along with control littermates.  The ChIP experiments 
demonstrated that the promoters of SREBP-1c target genes ME1, Scd1 and Gapt are 
indeed co-occupied by DMAP1 and Dnmt1 in wild-type livers, consistant with a 
repressive role on these SREBP-1c target genes.  Furthermore, Mat1 deletion in livers 
resulted in decreased occupancy of both DMAP1 and Dnmt1 on all the analyzed SREBP-
1c target gene promoters. Mat1 deletion also resulted in increased occupancy of SREBP-
1 on these genes. These data suggest that the induction of SREBP-1c dependent mRNAs 
following Mat1 depletion in hepatocytes is due to loss of co-repressor DMAP1 and 
Dnmt1 from and recruitment of SREBP-1c to promoters of ME1, Gpat1 and Scd1. 
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These findings reveal a novel transcriptional repressor function for mammalian Mat1 in 
the regulation of hepatic lipid metabolism through SREBP-1c in vivo. The results 
demonstrate that Mat1 is required for the maintenance of appropriate levels of lipogenic 
SREBP-1c target genes and promoter occupancy of both DMAP1 and Dnmt1 on SREBP-
1c target genes in hepatocytes, indicating that in a healthy liver SREBP-1c target genes 
are repressed through the recruitment of co-repressor DMAP1 and the DNA 
methyltransferase Dnmt1 by Mat1. The discovery that Mat1 and Cdk7 are significantly 
decreased both at mRNA and protein level in fatty livers of diabetic db/db mice 
implicates that downregulation of the Cdk7 kinase complex may play a role in the 
development of obesity-related hepatosteatosis. 
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DISCUSSION AND PERSPECTIVES 
 
 
The use of Cre-mediated Mat1 deletion in cell culture and tissue-specific mouse models 
used in this study has for the first time clearly established a general role for Mat1 and the 
TFIIH kinase in RNAP II CTD Ser5 phosphorylation and transcription in mammalian 
cells. Furthermore, the approach has revealed novel gene- and tissue-specific functions 
for Mat1 and the TFIIH kinase both as an activator (PGC-1 mediated transcriptional 
activation in cardiomyocytes) and as a repressor (PPARγ inhibitory phosphorylation in 
preadipocytes; recruitment of DMAP1 and Dnmt1 to SREBP-1c target genes in 
hepatocytes). The results attained during this thesis work provide important novel 
discoveries in mechanisms of basic science but also offer potential new therapeutic 
windows for diseases such as type II diabetes, hepatosteatosis and the metabolic 
syndrome. 
 
Mat1, Cdk7 and RNA Polymerase II CTD phosphorylation 
 
The data presented here provides compelling evidence that in mouse embryonic 
fibroblasts, Cdk7 is the main Ser5 RNAP II CTD kinase (I). Although it is formally 
possible that the depletory effect on Ser5 following Mat1 deletion in MEFs would be 
mediated independently of Cdk7, this appears unlikely as in all model systems used in 
this thesis as well as in other studies, Cdk7 levels and kinase activity decrease following 
Mat1 ablation. Furthermore, no Cdk7-independent functions of Mat1 have been 
described. As TFIIH has been mainly associated with PIC formation at the promoter 
region and not associated further along genes (Cheng and Sharp, 2003; Donner et al., 
2010; Gomes et al., 2006; Morris et al., 2005), the Ser5 phosphorylation of RNAP II 
during elongation has been attributed to some other CTD kinase. However, our results 
show that Ser5 phosphorylation decreases also in gene bodies (I). This suggests that 
either a) Cdk7 is in fact the kinase responsible for the majority of all RNAP II CTD Ser5 
phosphorylation events independent of where RNAP II is located on a gene b) Mat1 
additionally regulates some other downstream Ser5 kinase or c) TSS Ser5 
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phosphorylation is necessary for the action or recruitment of a second, downstream Ser5 
kinase. Mat1-/- MEFs also demonstrated globally reduced Ser2 phosphorylation (I). As 
Cdk7 has not been shown to phosphorylate Ser2, the observed decrease in Ser2 
phosphorylation is most probably due to the lack of recruitment of a Ser2 kinase, for e.g. 
Cdk9 (Guiguen et al., 2007; Viladevall et al., 2009), as a result of decreased Ser5-P 
levels. 
 
In tissues, the role of Mat1 and Cdk7 in RNAP II CTD phosphorylation appears to be 
more complicated. Deletion of Mat1 in myocardium did not reveal defects in global Ser5 
levels (III), although the possibility –and probability- of reduced levels of the Ser5-P 
form of RNAP II on specific genes exists. On the other hand, different genes may have a 
differential requirement for the amount of Ser5 phosphorylated RNAP II. This is 
supported by the ChIP analysis of Ser5-P levels from Mat1-deficient livers: although 
SREBP-1c target genes have 30-50% less Ser5 phosphorylated RNAP II in Mat1- deleted 
livers compared to heterozygous littermates, the mRNA levels of these genes are 
increased. Another interpretation of the results is that some tissues may contain another 
(or other) RNAP II Ser5 kinase(s). Alternatively, although Cdk7 may be the major CTD 
Ser5 kinase in all mammalian cells under unperturbed circumstances, certain tissues may 
be able to re-direct the substrate specificity of another kinase towards Ser5 when Cdk7 
activity is depleted.  For example, the HIV Tat protein is able to re-target Cdk9 to 
phosphorylate Ser5 (Zhou et al., 2000). In support of this, the timescale between the cell 
culture and in vivo mouse studies must be considered: in the MEF model, immediate 
effects of Mat1 deletion are investigated, whereas the Mat1-deficient tissues are analyzed 
weeks and months later, giving the cells time to possibly compensate for the lack of Cdk7 
kinase activity. The conditional Mat1 mouse models generated during these studies 
would therefore provide an excellent tool for the discovery of novel RNAP II CTD Ser5 
kinases.    
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Tissue-specific roles of Mat1 
 
Three of the studies presented here highlight a role for Mat1, and in the case of 
adipogenesis also for Cdk7, in metabolism (II-IV). PGC-1α has been shown to act as a 
co-activator of PPARα and PPARγ (Puigserver et al., 1998; Vega et al., 2000), and 
SREBP-1c as an upstream regulator of PPARγ (Fajas et al., 1999; Kim et al., 1998). 
Therefore, one might contemplate the possibility that as these pathways are 
interconnected, all the observed tissue-specific defects could be in fact mediated by the 
same mechanism. This remains highly unlikely based on tissue-specific expression 
patterns of PPARs, PGC-1 and SREBP-1c. Furthermore, our data demonstrated that Mat1 
deletion in MEFs resulted in differentiation towards white adipocytes (II), whereas PGC-
1α is implicated in the brown adipocyte phenotype (Puigserver et al., 1998). In the Mx1-
Cre;Mat1flox mouse model, the primary culprit of triglyceride accumulation was PPARγ 
based on previous in vitro findings (Compe et al., 2005) and our own earlier data from 
MEFs, but neither PPARγ nor PPARα demonstrated defective activation (IV). 
Furthermore, the mode of action in each case was demonstrated to be different. In 
adipocyte differentiatation, the Cdk7 subunit phosphorylates and inhibits PPARγ thereby 
indirectly influencing transcription of downstream targets, whereas in hepatocytes, the 
mode of transcriptional repression occurs directly on promoters of SREBP-1c target 
genes via recruitment of the co-repressor DMAP1 and the DNA methyltransferase 
Dnmt1.  
 
The unexpectedly minor role of the mammalian TFIIH kinase in global transcription in 
the analyzed tissues and differentiating cells is interesting in regard of described 
physiological settings with active mRNA transcription regardless of reduced TFIIH 
kinase activity or Ser5 phosphorylation. The cell cycle in budding yeast is one such case: 
quiescent cells lack detectable levels of Ser5-P and Ser2-P, yet 460 stationary-phase 
specific genes are actively transcribed (Radonjic et al., 2005). Cdk7 kinase activity and 
Ser5-P are repressed also during mitosis in mammalian cells, yet at least β-actin and 
cyclin B1 mRNAs are actively synthesized (Long et al., 1998; Sciortino et al., 2001; Xu 
and Manley, 2007).  The work in this thesis demonstrates that mouse adipose tissue lacks 
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detectable levels of Mat1 and Cdk7 (II); nevertheless, adipocytes are transcriptionally 
active, demonstrating that TFIIH kinase-independent transcription occurs in certain 
tissues in vivo. Both Mat1 and Cdk7 are downregulated during adipocyte differentiation 
to permit activation of PPARγ (ΙΙ),  suggesting a model where in certain circumstances 
the general TFIIH kinase elongation function identified in MEFs can be compromised 
when inhibition of TFIIH kinase is beneficial or critical for other functions (Figure 7). 
Furthermore, in the liver, Mat1 has a repressive modulatory function in transcription, 
which appears to be crucial for the maintenance of appropriate levels of SREBP1 target 
mRNAs (IV).  
 
mRNA stabilization: linking transcription progression to mRNA turnover 
 
Perhaps the most novel and intriguing discovery of this thesis work was the finding that 
the perturbation of transcription by Mat1 deletion in MEFs resulted in prolonged mRNA 
half-lives (I). A similar phenomenon has been previously observed in budding yeast 
following oxidative stress (Molina-Navarro et al., 2008) and in mammalian cells treated 
with transcriptional inhibitors (Meininghaus et al., 2000), but this has not been widely 
acknowledged.  
 
How might mRNAs be stabilized at a global level? An obvious mechanism that emerges 
is the retention of mRNAs in the nucleus by blocking nuclear export. However, if this 
were the case, Mat1-/- MEFs would have shown decreased protein levels (unless a 
simultaneous stabilization of proteins occurred), which were not observed. A second 
possible mechanism is via capping-dependent regulation of translation The majority of 
mRNAs are translated in a cap-dependent manner (Van Der Kelen et al., 2009). As the 
Mat1-/- MEFs demonstrated defective capping of most analyzed mRNAs, this could result 
in slower translation which would naturally increase the half-lives of the mRNAs. If the 
translation rate would not form a bottle-neck, such a defect would not be detected in total 
protein levels, similar to DRB-treated HeLa cells, where inhibition of Cdk7 activity slows 
down capping without having an effect on the amount of capped end product (Moteki and 
Price, 2002). A third possibility worth considering is the binding of stabilizing, protective 
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proteins to mRNAs. These proteins would have to be general rather then the sequence-
specific ARE-binding proteins. For example, poly(A) binding proteins (PABPs) prevent 
deadenylation of mRNAs by binding to the poly(A) tail and hence protect the mRNA 
from degradation (Bernstein et al., 1989). PABPs have been shown to interact with the 
5’cap structure, thereby providing a possible communication link between transcription 
and translation. 
 
This discovery of altered mRNA turnover raises the question whether this phenomenon 
takes place in vivo. For example, might the cardiomyopathy observed in αMHC-
Mx1;Mat1-/- mice simply reflect a timing issue: Mat1-deficient cardiomyocytes are able 
to maintain protein levels by stabilizing mRNAs but only for a certain period of time, 
eventually resulting in lethality. What does the nascent mRNA profile of white 
adipocytes look like: do they exhibit altered mRNA turnover compared to 
undifferentiated cells? All in all, these findings warrant the necessity of utilizing nascent 
mRNAs rather then mRNA steady-state levels for reliable conclusions concerning 
transcriptional activity in any given system.    
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Figure 7. Summary of the roles of mammalin Mat1 in transcriptional activation and repression. (a) 
In undifferentiated and proliferating cells, such as preadipocytes and mouse embryonic fibroblasts (MEFs), 
Mat1 is required for the stability of the Cdk7 kinase module to TFIIH and for phosphorylation of Ser5 of 
RNAP II CTD (1). Ser5 phosphorylation is crucial for the recruitment of the cap complex (2), which in turn 
is required for recruitment of P-TEFb to phosphorylate RNAP II CTD on Ser2 residues (3). These 
consecutive steps are required for efficient transcription elongation to produce the nascent mRNA reflected 
in the levels of total mRNA. Furthermore, thep preadipocyte state is maintained through the inhibitory 
phosphorylation of Ser112 of PPARγ by Mat1/Cdk7 (4). (b) Upon Mat1 deletion, Cdk7 is unable to bind to 
the rest of TFIIH, Ser5 phosphorylation of RNAP II CTD does not occur and the cap complex and P-TEFb 
are not recruited to the site of transcription (1). This results in transcriptional attenuation and decreased 
nascent mRNA amounts. This defect is not reflected in the majority of total mRNA, suggesting the 
existence of a global mRNA stabilizing mechanism (2). Due to loss of Cdk7 activity, PPARγ is no longer 
maintained in a phosphorylated state, and in the presence of appropriate hormonal cues, differentiation into 
adipocytes can take place (3). (c) In some terminally differentiated tissues  (e.g. WAT) and during the 
differentiation process as well as pathophysiologies like hepatosteatosis, Mat1 and Cdk7 protein levels are 
downregulated (1). This leads to activation of specific transcriptional pathways, depending on tissue and 
cell type (2), suggesting that the general transcriptional function demonstrated in a-b can be compromised 
in circumstances where downregulation of Mat1/Cdk7 is required. Whether specific tissues and 
differentiation processes require an alternate RNAP II CTD Ser5 kinase (3), display differences in 
recruitment of cap complex, P-TEfB and  synthesis of nascent mRNA (4) and possible stabilization of 
mRNA remains to be studied. 
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